US46121Y2019 - Common Stock
Taking everything into account, IPI scores 7 out of 10 in our fundamental rating. IPI was compared to 122 industry peers in the Chemicals industry. IPI scores excellent points on both the profitability and health parts. This is a solid base for a good stock. A decent growth rate in combination with a cheap valuation! Better keep an eye on IPI. This makes IPI very considerable for value investing!.
ROA (35.03%) VS Industry: 100% outperformed.
ROE (40.22%) VS Industry: 84% outperformed.
Profit Margin (91.93%) VS Industry: 100% outperformed.
Price/Earnings (15.08) VS Industry: 46% outperformed.
Price/Book (1.2) VS Industry: 82% outperformed.
Enterprise Value/ EBITDA (7.5) VS Industry: 66% outperformed.
Debt/Equity (0) VS Industry: 90% outperformed.
Quick Ratio (1.65) VS Industry: 61% outperformed.
Current Ratio (2.75) VS Industry: 69% outperformed.
Altman-Z (5.81) VS Industry: 86% outperformed.
NYSE:IPI (5/27/2022, 10:32:58 AM)-3.7 (-5.73%)
|Earnings (Last)||05-02 2022-05-02/amc||Earnings (Next)||08-01 2022-08-01|
|Ins Owners||14.55%||Inst Owners||52.86%|
|PEG (NY)||0.04||PEG (5Y)||N/A|
|EPS 1Y||399.26%||EPS 3Y||28.28%|
|EPS 5Y||N/A||EPS growth Q2Q||1188.89%|
|EPS Next Y||394.19%||EPS Next 2Y||65.3%|
|EPS Next 3Y||24.15%||EPS Next 5Y||-5.74%|
|Revenue growth 1Y||48.3%||Revenue growth 3Y||9.08%|
|Revenue growth 5Y||4.97%||Revenue growth Q2Q||46.01%|
|Revenue Next Year||42.65%||Revenue Next 2Y||6.12%|
|Revenue Next 3Y||1.65%||Revenue Next 5Y||-5.07%|
|Current Ratio||2.75||Quick Ratio||1.65|
|Dividend Yield||N/A||Dividend Growth||N/A|
Find stocks with similar Fundamental rating on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA